TO RECALL 1 Flashcards
Drug:
AMIODARONE
- drug for cardiac arrythmias
- has multiple receptors (i.e. nuclear thyroid hormone receptor) - contributes to its toxicity
Drug:
SOTALOL
- Beta-blocker
- used as an anti-arrythmic
- Given as a racemic mixture where both L- and D- enantiomers are equipotent K+ channel blockers BUT L- as the more potent Beta-adrenergic antagonist
Example for The Specificity of Drug Responses
Drug:
Nitrovasodilators
- treats angina where NO-dependent elevation of cGMP in vascular smooth muscle produces vasodilation
- chronic administaration results in complete tolerance (Tachyphylaxis)
Drug:
VARENICLINE
- used for smoking cessation therapy
- partial agonist of nicotinic receptors
Drug:
SIDENAFIL, TADALAFIL, VARDENAFIL
- phosphodiesterase (PDE) 5 inhibitors
- in vasculature
- SIDENAFIL - treatment for erectile dysfunction
- co-administration with nitrovasodilators can cause catastrophic vasodilation & severe hypotension
Drug:
WARFARIN
- oral anticoagulant
- has a narrow margin between therapeutic inhibiton of clot formation and bleeding complications
- Antibiotics (decrease vit. K absorption) & NSAIDS (i.e. Aspirin that inhibits platelet aggregation) will enhance effect of warfarin - AT RISK FOR BLEEDING
Drug:
ALPHA-METHYL TYROSINE
- inhibits synthesis of norepinephrine
Drug:
COCAINE
- BLOCKS Norepinephrine uptake
Drug:
AMPHETAMINE
- promotes NE release
- similar effect to cocaine
Drug:
SELEGILINE
- inhibits NE breakdown by MAO (Monoamine Oxidase)
Drug:
FUROSEMIDE, CHLOROTHIAZIDE, AMILORIDE
- Diuretics
- affects ion pumps & transporters to increase movement of Na+ into the urine
Drug:
OMEPRAZOLE
- Proton pump inhibitor (H+-K+ ATPase)
Drug:
TERBUTALINE
- Beta 2 adrenergic agonist
- used for broncodilation in asthma
Drug:
Sulfonylureas & Meglitinides
- oral hypoglycemic drug (lowers blood sugar)
- activate Beta cells to increase insulin release in pancreas
- used in treatment of type II diabetes mellitus
Sulfonylureas - target ATP-sensitive potassium channels
Meglitinides - target sulfonylurea receptor 1 (SUR1)
Drug:
LIDOCAINE & TETRACAINE
- Local anesthetics
- block voltage-gated Na+ channels in pain neurons to inhibit depolarization
Drug:
NIFEDIPINE, DILTIAZEM, VERAPAMIL
- Ca+ channel antagonist/blockers
- blocks muscle contraction in blood vessels leading to vasodilation
Drug:
ROCURONIUM
- competitive antagonist of acetylcholine
- Muscle Relaxant
Drug:
NESIRITIDE
- Synthetic BNP agonist
- used in treatment of acute decompensated heart failure
Drug:
SACUBITRIL
- neprilysin inhibitor
- blocks ANP & BNP breakdown
- treats decompensated heart failure
Drug:
ATROPINE
- blocks acetylcholine (parasympathetic ligand)
Drug:
DOBUTAMINE
- Beta 1 receptor agonist
- increase strength of heart contractions
Drug:
TETRABENZINE
- Symptomatic treatment for your Huntington disease - Antichorea (chorea: movement disorder)
- inhibits (SLC18A2) VMAT2: Vesicular monoamine transporter - function to store amines (i.e. Dopamine)
Drug:
CANAGLIFLOZIN, DAPAGLIFLOZIN, EMPAGLIFLOZIN
- Inhibits SLC5 family transporters SGLT1 & SGLT2 (Na+-glucose transporters)
- treatment for diabetes
- reduces renal reabsorption of glucose, leading to glucose elimination
at the proximal convoluted tubules
Drug:
LESINURAD
- Treatment for gout
- targets (SLC22A12) URAT1 (Uric Acid Transporter 1) to inhibit uric acid reabsorption in the kidney
at the proximal convoluted tubules
Drug:
IVACAFTOR
- used in treatment for cystic fibrosis
- a potentiator that increases the probability that the mutant chloride channel (CFTR-G551D) remains open
Drug:
PARAVASTATIN
- HMG-CoA reductase Inhibitor
- used to reduce amount of ‘bad cholesterol’
- functions through uptake by SLC OATP1B1 in liver
- when it does not enter the liver, an adverse response is skeletal muscle myopathy
Drug:
LOPERAMIDE
- Peripheral opioid
- for diarrhea
- Do not mix with Quinidine (potent Pgp inhibitor)